Showing 8,601 - 8,620 results of 30,761 for search '(( 2 step decrease ) OR ( 50 ((((we decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.16s Refine Results
  1. 8601
  2. 8602
  3. 8603

    ADPβS had no effect on two physiologic parameters of Mü ller cell gliosis by Ortrud Uckermann (82321)

    Published 2011
    “…</p><p></p> (A) Example of a calcium imaging record in two endfeet of Müller cells in a 48 h-detached retina. …”
  4. 8604
  5. 8605

    Actions to Include in a Farm Environment Plan by Annabel McAleer (15329209)

    Published 2024
    “…This interactive infographic is a compilation of actions to decrease the loss of contaminants from agricultural land. …”
  6. 8606

    Selective Inhibitors of Janus Kinase 3 Modify Responses to Lipopolysaccharides by Increasing the Interleukin-10-to-Tumor Necrosis Factor α Ratio by Julian Laux (13047767)

    Published 2023
    “…., tofacitinib, 0.2–0.4 μmol/kg bid) in clinical use, suggesting an efficient underlying mode of action. We hypothesized that their effectiveness is due to their ability to raise the ratio of IL-10 to TNFα. …”
  7. 8607

    Supplementary materials. by Yongki Welliam (21030005)

    Published 2025
    “…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
  8. 8608
  9. 8609

    PfSUB2PD Inhibits MESH in a Selective, Dose-Dependent Manner by Philippa K Harris (27615)

    Published 2013
    “…<div><p>(A) Shedding of AMA1 and MSP1 from isolated merozoites was assayed in the presence of the indicated additives. Two different batches (1 and 2) of purified PfSUB2PD were tested, in each case alongside a similar dilution of the membrane flow-through (Conc FT) from the final step of concentration by ultrafiltration. …”
  10. 8610
  11. 8611

    Summary of subgroup analysis results. by Yongki Welliam (21030005)

    Published 2025
    “…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
  12. 8612

    PRISMA Flow Chart 2020. by Yongki Welliam (21030005)

    Published 2025
    “…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
  13. 8613

    Included and excluded studies. by Yongki Welliam (21030005)

    Published 2025
    “…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
  14. 8614

    Characteristics of included studies. by Yongki Welliam (21030005)

    Published 2025
    “…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
  15. 8615

    Extraction data table. by Yongki Welliam (21030005)

    Published 2025
    “…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
  16. 8616
  17. 8617

    Transforming Small-Molecule Nanoaggregation into Functional Drug Delivery Platforms by JunHyuk Kim (21235657)

    Published 2025
    “…The IC<sub>50</sub> value of <b>Nano-CC1-Acl</b> further decreases to 0.20 ± 0.16 μM in the presence of cysteine, a biothiol. …”
  18. 8618

    Transforming Small-Molecule Nanoaggregation into Functional Drug Delivery Platforms by JunHyuk Kim (21235657)

    Published 2025
    “…The IC<sub>50</sub> value of <b>Nano-CC1-Acl</b> further decreases to 0.20 ± 0.16 μM in the presence of cysteine, a biothiol. …”
  19. 8619

    Cisd2 deficiency disrupts Ca<sup>2+</sup> homeostasis via a dysregulation of Serca2a activity and this then results in mitochondrial Ca<sup>2+</sup> overload and dysfunction in car... by Chi-Hsiao Yeh (7474556)

    Published 2019
    “…Scale bar, 5 μm. (N) Serca2a (Ca<sup>2+</sup>-ATPase) activity was measured as the decrease in the absorbance at 340 nm using heart tissue from the various genotypes. …”
  20. 8620